Abstract
Bacillus Calmette-Guerin administered intravenously or by aerosol to rhesus monkeys induced a much greater degree of protection against aerosol challenge with virulent Mycobacterium tuberculosis than intracutaneous bacillus Calmette-Guerin vaccination. the aerosol route of vaccination was not associated with any obvious adverse side effects and produced a very small degree of tuberculin skin hypersensitivity. Aerosol vaccination should be examined further to determine its potential application for vaccinating humans against tuberculosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
